Hazlett, Burt & Watson, Inc. Aerie Pharmaceuticals Inc Transaction History

Hazlett, Burt & Watson, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	SELL	$6.37 - $15.23 $1,433 - $3,426	-225 Reduced 1.0%	22,200 $338,000
Q2 2022 Aug 03, 2022	SELL	$4.95 - $9.16 $1,113 - $2,061	-225 Reduced 0.99%	22,425 $171,000
Q1 2022 May 05, 2022	BUY	$5.64 - $9.8 $127,746 - $221,970	22,650 New	22,650 $207,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Hazlett, Burt & Watson, Inc., based on Form 13F filings with the SEC.

Stay updated on Hazlett, Burt & Watson, Inc. with notifications on news.